small molecule inhibitors

Related by string. small molecule inhibitor * smaller . Smaller . Smalls . SMALL : Small Cap Index . Chris Smalling . Small Cap Value . Small Cap Growth / Molecules . Molecule . molecules : small molecule therapeutics . stranded RNA molecules . dye molecules . small molecule / Inhibitor . Inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . ACE inhibitors . proton pump inhibitor PPI * *

Related by context. All words. (Click for frequent words.) 73 small molecule inhibitor 72 FGFR 71 kinase inhibitor 71 selective inhibitors 71 potent inhibitors 71 HDACs 70 IGF 1R 70 HDAC inhibitors 70 novel peptide 70 kinase inhibitors 70 proteasome inhibitors 70 selective inhibitor 70 peptides 70 fusion proteins 69 small molecule modulators 69 hedgehog pathway 69 selective inhibition 69 FLT3 69 protein kinase inhibitor 69 polymerase inhibitors 69 Hedgehog pathway 69 small molecule 69 BCR ABL 68 HDAC 68 VEGF receptor 68 Hsp# inhibitors 68 TLR8 68 JAK1 68 immunomodulatory 68 HCV protease 68 antisense oligonucleotides 68 anticancer therapies 68 potent inhibitor 68 kinase 67 proteases 67 JAK2 67 c MET 67 siRNA therapeutics 67 PARP inhibitors 67 kinases 67 serine protease 67 PI3 kinase 67 ENMD # 67 molecular biomarkers 67 histone deacetylase 67 P#X# 67 antisense oligonucleotide 67 protein kinases 67 receptor antagonists 67 HSP# inhibitor 67 anticancer agents 67 M2 subunit 67 NS5A 67 tyrosine kinases 67 fusion protein 67 histone deacetylase inhibitors 67 tyrosine kinase inhibitor 67 MEK inhibitors 67 JAK2 inhibitors 66 induce apoptosis 66 PI3K 66 synthetic peptides 66 humanized monoclonal antibody 66 Hedgehog signaling pathway 66 oncogenic 66 MDM2 66 JAK3 66 TLR9 agonists 66 humanized antibody 66 SIRT2 66 anticancer drugs 66 TLR7 66 agonist compounds 66 nucleosides 66 MAPK 66 predictive biomarkers 66 peptide antigens 66 anti angiogenic 66 PI3K inhibitor 66 cyclin dependent kinases 66 Fibroblast Growth Factor Receptor 66 small molecule defensin 66 molecularly targeted 66 Preclinical studies suggest 66 MEK inhibitor 66 protein kinase C 66 peroxisome proliferator activated 66 prodrugs 66 antisense drugs 66 investigational humanized monoclonal antibody 66 HDAC inhibition 66 ErbB3 HER3 65 HuLuc# 65 small molecule activators 65 NS4A 65 IL 1β 65 ligands 65 Flt3 65 UsiRNAs 65 monoclonal antibodies 65 Factor Receptor 65 tyrosine kinase inhibitors 65 Curaxins 65 GSK3B 65 siRNA therapeutic 65 E#F# 65 chemokine 65 apoptotic pathway 65 enveloped viruses 65 ErbB3 65 selectively inhibit 65 JAK2 inhibitor 65 nucleoside analogues 65 antibody fragment 65 humanized monoclonal antibodies 65 BAL# [001] 65 RNA antagonist 65 PLK1 65 orally bioavailable 65 phosphatases 65 glucagon receptor 65 Fc fusion protein 65 EGF receptor 65 potently inhibit 65 allosteric 65 HDACi 65 kinase inhibition 65 CCR2 65 enzyme inhibitors 65 S1P 65 short interfering RNA 65 antagomirs 65 phosphate S1P 65 siRNAs 65 CTLA 4 65 targeting CD# 65 antiviral compounds 65 VEGF receptors 65 FGFR1 64 PDGF receptor 64 immune stimulatory 64 cellular pathways 64 G Protein Coupled 64 RNAi therapeutic targeting 64 PI3K/mTOR 64 tumor vasculature 64 SGLT2 64 Aurora kinase 64 IAP inhibitor 64 aptamers 64 mAbs 64 immunoregulatory 64 factor receptor FGFR 64 deacetylase inhibitors 64 proto oncogene 64 A3 adenosine receptor 64 anticancer compounds 64 inhibitors 64 cyclin dependent kinase inhibitor 64 immunotherapeutic 64 synthetic peptide 64 selectively inhibits 64 receptor agonists 64 S#P# 64 PTP 1B 64 MAPK pathway 64 HDAC6 64 anticancer therapeutics 64 GSK3 64 therapeutic monoclonal antibodies 64 multi kinase inhibitor 64 histone methyltransferases HMTs 64 humanized anti 64 androgen receptor AR 64 MUC1 64 HDAC inhibitor 64 ETBs 64 enzyme inhibitor 64 CXCR4 64 immunomodulator 64 glycosylated 64 epothilone 64 histone deacetylases 64 survivin 64 small molecule agonists 64 receptor tyrosine kinase 64 myelofibrosis polycythemia vera 64 uPAR 64 HER3 64 Protein Kinase C 64 JAK inhibitors 64 epothilones 64 ligases 64 Hsp# inhibition 64 BRAF kinase 64 peptide 64 p# mitogen activated 64 oncolytic 64 pDCs 64 adenoviral 64 PPARγ 64 antitumor 64 micro RNAs 64 cell signaling pathways 64 EGFR inhibitors 64 preclinically 64 Wnt signaling pathway 64 preclinical compounds 64 Nanobodies 64 SERMs 64 Smac mimetics 63 VEGFR 63 catenin 63 kinase enzymes 63 monoclonal antibody mAb 63 E3 ligase 63 miR #a [002] 63 mediated apoptosis 63 Sphingomab 63 humanized antibodies 63 proteasome inhibitor 63 GPCR targets 63 EGFr 63 IGF IR 63 siRNA 63 vascular disrupting agents 63 kinase pathway 63 pan HDAC inhibitor 63 dimerization 63 selective kinase inhibitor 63 Notch1 63 Kinase 63 TGF β 63 chemically modified siRNA 63 peptidomimetic 63 SOD1 63 hypoxia inducible factor 63 druggable targets 63 p# inhibitors 63 small molecule activator 63 c MYC 63 NF kB pathway 63 TNFa 63 STAT3 63 chemotherapeutics 63 selective antagonist 63 V#F mutation 63 oncogenes 63 insulin sensitizers 63 CD# [002] 63 PI3K Akt 63 sigma receptors 63 inhibit viral replication 63 cancer therapeutics 63 VEGFR2 63 geldanamycin 63 antisense inhibitor 63 tumor antigen 63 Epidermal Growth Factor Receptor 63 induces apoptosis 63 tyrosine kinase 63 signaling cascades 63 tumor antigens 63 receptor tyrosine kinase inhibitor 63 cytoprotective 63 isoform selective 63 NKG2D 63 glucocorticoid receptor 63 Nanobody ® 63 peptibody 63 tumorigenesis 63 phosphatidylinositol 3 63 chemokine receptor 63 gamma secretase inhibitors 63 antisense compounds 63 immunotherapeutics 63 DsiRNA 63 transient receptor 63 preclinical studies 63 AEG# 63 beta catenin 63 tumor suppressor protein 63 melanocortin receptors 63 Skp2 63 signaling pathway 63 PPARg 63 sphingosine 1 63 MEK ERK 63 potent inhibition 63 mTOR inhibitors 63 CENP E 63 mda 7 63 gastrin 63 Hypoxia Inducible Factor 63 polymerase inhibitor 63 XmAb# 63 recombinant antibodies 63 poly ADP ribose polymerase 63 PARP inhibitor 63 RGB # 63 immune modulation 63 multitargeted 63 Kinases 63 phosphoinositide 3 63 reverse transcriptase 63 cyclin E 63 erlotinib Tarceva ® 63 clusterin 63 PI3K inhibitors 63 Factor VIIa 63 CYT# potent vascular disrupting 63 resolvins 63 HepDirect prodrug 63 TLR9 63 cancer immunotherapies 63 selective antagonists 62 cathepsins 62 GPR# [002] 62 cyclins 62 EGFR 62 dAbs 62 activin 62 ErbB 62 Tyrima 62 CTGF 62 metabolic enzymes 62 anti CD3 62 antisense 62 antisense inhibitors 62 CD# monoclonal antibody 62 thyroid hormone receptor 62 reversible inhibitor 62 targeted antifolate 62 biased ligands 62 splice variants 62 Clusterin 62 miRNAs 62 PI3 K 62 LRRK2 62 monoclonal antibody 62 vascular disrupting agent 62 small interfering RNA 62 FGFR3 62 Anticalin 62 histone deacetylase HDAC 62 TLR agonists 62 Eg5 62 mGluR2 NAM 62 anti fibrotic 62 signaling pathways 62 glutamate receptors 62 epigenetic enzymes 62 adenosine receptor 62 proteins 62 IAP inhibitors 62 xenograft models 62 Locked Nucleic Acid LNA 62 pRb 62 TLR9 agonist 62 PCSK9 62 pro apoptotic 62 c Raf kinase 62 neuropilin 62 polypeptides 62 plectasin 62 immunomodulating 62 tumor suppressors 62 vimentin 62 AT1R 62 shRNAs 62 Abl 62 histone deacetylase HDAC inhibitors 62 estrogen receptor beta 62 bioactive lipids 62 partial agonist 62 Cdc7 62 myeloma cells 62 delta isoform 62 tumor suppressor genes 62 microRNAs 62 biomarkers 62 antibody 62 oncolytic viruses 62 glycolipids 62 immunotherapies 62 receptor subtypes 62 CDK inhibitor 62 inhibitor 62 shRNA libraries 62 secreted protein 62 HCV polymerase inhibitors 62 5 HT6 62 T#I mutant 62 targeting PCSK9 62 small molecule tyrosine 62 antitumoral 62 integrin receptors 62 albumin binding 62 E2F 62 CDKs 62 siRNA binds 62 DNA methyltransferases 62 otelixizumab 62 Sym# 62 nucleoside 62 tyrosine kinase receptor 62 Janus kinase 62 immunogens 62 NF kappa B 62 disease modifying 62 PKC isoforms 62 CYC# 62 hormone gastrin 62 CRAC channel 62 Debio 62 ERK pathway 62 vitro studies 62 anticancer agent 62 HDAC enzymes 62 siRNA compounds 62 HIV protease 62 GPCR 62 anionic backbone 62 VEGF pathway 62 histone deacetylation 62 costimulatory 62 interferon gamma 62 angiogenesis inhibitor 62 CRTH2 62 CCX# 61 BRAF mutation 61 nicotinic acetylcholine receptor 61 preclinical models 61 upregulate 61 TLRs 61 covalent drugs 61 bispecific 61 mitotic kinesin 61 PDGFR 61 Preclinical studies 61 coactivator 61 signal transduction inhibitor 61 anti angiogenic drugs 61 mitogen activated protein kinase 61 Kv#.# 61 PKM2 61 Aurora kinases 61 TTR gene 61 EZH2 61 CCR3 61 NS3 61 PEGylated 61 CB2 receptor 61 CCR9 61 siRNA mediated 61 orphan GPCRs 61 4E BP1 61 mTOR pathway 61 binding proteins 61 NF kB 61 oncoproteins 61 serine threonine kinase 61 LNP formulations 61 USP# 61 WT1 61 molecular pathways 61 glioma cells 61 epitopes 61 NEUGENE 61 mitotic kinesins 61 signal transduction pathways 61 HCV protease inhibitors 61 GPCRs 61 c myc 61 antisense molecules 61 histone deacetylases HDACs 61 MAbs 61 myeloproliferative disorders 61 oral prodrug 61 Receptors GPCRs 61 CBLC# 61 ALN TTR 61 viral proteins 61 integrase inhibitors 61 Symadex 61 histone deacetylase inhibitor 61 human monoclonal antibody 61 Guanilib 61 lentiviral vectors 61 Factor VEGF 61 FK# 61 MEK1 61 interferon IFN 61 tkRNAi 61 Tumor Necrosis Factor 61 metalloprotease 61 shRNA 61 Nedd4 61 protease 61 inhibiting tumor 61 MDSCs 61 Inhibitor 61 T#M 61 CORT # 61 mimetics 61 serine threonine kinases 61 Survivin 61 Syk 61 CCR9 antagonist 61 HCV polymerase inhibitor 61 agonists 61 CD# antibody [001] 61 Hsp# inhibitor 61 aurora kinase 61 receptor agonist 61 antibody therapeutics 61 PI3K/Akt pathway 61 ERK1 2 61 STK# [002] 61 oncogenesis 61 imatinib Gleevec 61 sodium glucose cotransporter 61 FAAH 61 androgen receptor 61 short hairpin RNAs 61 Aurora kinase inhibitor 61 CDK inhibitors 61 PAK1 61 SGLT inhibitors 61 druggable 61 TGF Beta 61 ribonuclease 61 PDE4 inhibitor 61 Anticalins ® 61 CCR5 antagonist 61 chemokine receptors 61 eIF 4E 61 vitro assay 61 transgenic mouse model 61 cyclin dependent kinases CDKs 61 AMPK activators 61 5 HT6 receptor 61 Chemokine Receptor 61 secreted proteins 61 Enzastaurin 61 hypermethylation 61 mGluR 61 oral JAK1 61 interleukins 61 Activating mutations 61 γ secretase 61 β catenin 61 serine threonine 61 p# MAPK 61 Tarvacin TM 61 nicotinic receptors 61 neuroprotective properties 61 IGFBP2 61 muscarinic 61 brain penetrant 61 methylated DNA 61 phosphorylate 61 Hsp# [002] 61 matrix metalloproteases 61 Bcl 2 61 K RAS 61 Anticalins R 61 SARMs 61 IMPDH 61 biomarker identification 61 GKAs 61 antibodies 61 cytotoxic 61 immune modulators 61 Aptamer 61 Squalamine 61 AtuRNAi 61 protein kinase inhibitors 61 tiapamil 61 imatinib Gleevec ® 61 adhesion molecule 61 Anticalins 61 JAK#/JAK# 61 #beta HSD1 61 serotonin receptor 61 humanized monoclonal 61 orally administered inhibitor 60 CXCR7 60 methyltransferases 60 IgG1 antibody 60 protein misfolding 60 Janus Kinase 60 receptor CXCR4 60 molecular pathway 60 antiviral therapeutics 60 PI3K delta 60 pertuzumab 60 NFκB 60 alpha folate receptor 60 TAp# 60 OXi# 60 FGFR2 60 neuroinflammation 60 C5aR 60 HSP# 60 antiangiogenic 60 mRNA translation 60 pharmacological chaperone 60 Pentraxin 2 60 receptor mediated 60 CTLs 60 ubiquitin ligase 60 single stranded oligonucleotides 60 derived neurotrophic factor 60 epigenetic mechanisms 60 nanocarriers 60 OMP #M# 60 Beta catenin 60 IFN alpha 60 Gleevec resistant 60 DNA intercalator 60 epithelial tumors 60 bifunctional 60 TRAIL receptor 60 CCR1 60 homodimers 60 tumor microenvironment 60 selective modulator 60 micro RNA 60 protein kinase 60 DLC1 60 depsipeptide 60 mAb 60 NS4B 60 NS#/#A protease 60 #HT#A 60 TLR8 agonist 60 FasL 60 CK2 60 tumorigenic 60 CB1 antagonists 60 chemotherapeutic agents 60 Galectins 60 ATL# [001] 60 novel peptides 60 non nucleoside 60 Kinase inhibitors 60 matrix metalloproteinases 60 2 inhibitor CYT# 60 highly selective inhibitor 60 metabotropic glutamate receptors 60 serine proteases 60 Nanobody 60 thrombin receptor 60 ligand 60 selectively inhibited 60 Pathway Inhibitor 60 virulence genes 60 protein tyrosine phosphatase 1B 60 NNRTIs 60 sphingosine kinase 60 DXL# 60 antibacterial compounds 60 constitutively active 60 therapeutic antibodies 60 thrombopoietin 60 vidofludimus 60 cysteine residues 60 bispecific antibodies 60 MDRNA proprietary 60 TrkA 60 GAP #B# 60 miR #a [001] 60 HIV integrase inhibitors 60 effector function 60 chaperone protein 60 TNFα 60 exosome 60 RON Notch 60 protein tyrosine phosphatases 60 reversible inhibitors 60 intracellular signaling 60 nucleoside analogs 60 LY# [003] 60 biologic therapeutics 60 oxidative stress inducer 60 taxanes 60 agonism 60 EpCAM 60 anti apoptotic 60 topoisomerase 60 EGFRvIII 60 intracellular protein 60 receptor gamma 60 selective agonist 60 gamma secretase inhibitor 60 DGAT 60 cilengitide 60 transmembrane proteins 60 transcriptional regulation 60 IgG1 60 cytotoxin 60 Monoclonal antibodies 60 immune modulating 60 leukemic cells 60 PXD# 60 BCR ABL inhibitors 60 bevacizumab Avastin ® 60 CD# CEA 60 Hsp# chaperone system 60 PIK3CA 60 IGF1R 60 LPA1 60 hTERT 60 Galectin 60 lipidoid 60 Src 60 PDE4 60 KLF4 60 exon skipping 60 preclinical 60 splice variant 60 Trp p8 60 engineered RAP peptides 60 protease inhibitors 60 HCV replication 60 oncoprotein 60 neurotrophic factor 60 Xanafide 60 RNase L 60 integrase 60 CDK4 60 ArQule Kinase Inhibitor Platform 60 DiLA2 60 NMDA receptor 60 antiproliferative activity 60 NFkB 60 siRNA molecules 60 epitope 60 #ME# 60 telomerase inhibitors 60 Angiolix 60 phosphatase 60 triphosphate 60 bispecific antibody 60 PPARgamma 60 VEGF inhibitors 60 ubiquitin ligases 60 monoclonal antibody MAb 60 Locked Nucleic Acid 60 BiTE 60 siRNAs targeting 60 nanoparticle formulation 60 activating mutations 60 HCV polymerase 60 TGF ß 60 cytokine 60 thymidylate synthase TS 60 phosphoprotein 60 topoisomerase II 60 small molecule thrombopoietin 60 drug conjugate 60 intracellular signaling pathways 60 prophylactic vaccine 60 lysosomal 60 Kinase Inhibitor 60 endogenous ligands 60 Vidofludimus 60 T#I [002] 60 ActRIIB 60 5 HT2A receptor 60 chemotherapeutic 60 constitutively activated 60 GRP# 60 oligomerization 60 prostaglandin synthesis 60 PAR1 60 allosteric modulator 60 beta amyloid peptide 60 RNAi pathway 60 systemically administered 60 EGFR pathway 60 dasatinib Sprycel 60 RNAi therapeutic 60 neutralizing antibody 60 anti CD# antibodies 60 mTOR 60 investigational monoclonal antibody 60 anti secretory 60 agonists antagonists 60 proapoptotic 60 Th# cells 60 non coding RNA 60 AKT inhibitor 60 glycoprotein 60 NPM1 60 inhibitory effects 60 PSN# [002] 60 c Myc 60 GPR# [001] 60 potent antiproliferative 60 prolyl 60 isoforms 60 tumor suppressor 60 Spiegelmers R 59 Posiphen 59 receptor 59 antiapoptotic 59 RANKL 59 neurite outgrowth 59 Blinatumomab 59 microtubule inhibitor 59 nucleoside analog 59 TMEM#B 59 novel immunomodulatory 59 nicotinic alpha 7 59 SGLT2 inhibitors 59 receptor molecule 59 siRNA molecule 59 TLR2 59 virulence factors 59 mutant protein 59 partial agonists 59 Th# 59 XL# inhibits 59 insulin sensitizer 59 mGluR4 59 cytotoxic agents 59 PI3 kinase inhibitors 59 siRNA delivery 59 antiviral therapies 59 chemoresistance 59 miRNA 59 siRNA sequences 59 EphA2 59 retinoic acid receptor 59 vivo 59 tyrosine phosphorylation 59 pro inflammatory cytokines 59 oncolytic virus 59 TNF receptors 59 lipopeptide 59 interferons 59 transcription factors 59 neuronal nicotinic receptors NNRs 59 Tarvacin 59 LHRH antagonists 59 Th2 cytokines 59 breast cancer metastasis 59 Htt 59 endostatin 59 trans splicing 59 PDE4 inhibitors 59 Epothilones 59 clinically validated targets 59 familial amyloidotic polyneuropathy FAP 59 SIRT1 activators 59 delipidation 59 CXCL5 59 extracellular domain 59 RNA sequences 59 Vascular Endothelial Growth 59 neurotrophic 59 glycosyltransferase 59 siRNA duplexes 59 neutralizing antibodies 59 cell signaling pathway 59 deacetylation 59 MAbs targeting 59 NF κB 59 novel kinase inhibitors 59 PPAR gamma 59 VEGF 59 Viprovex TM 59 ErbB2 59 ENaC 59 MET VEGFR2 59 biomarker 59 novel anticancer 59 renin inhibitors 59 polyketides 59 BiTE antibodies 59 liposomal formulation 59 Smurf1 59 ligand TRAIL 59 neurodegenerative diseases 59 biochemical assays 59 eotaxin 59 therapeutics 59 PGE2 59 Inhibitors 59 IMC A# 59 chemotherapeutic drugs 59 CXCR4 receptor 59 Ceflatonin 59 tumor suppressor gene 59 gene fusions 59 histone deacetylase HDAC inhibitor 59 DHFR 59 JAK2 kinase 59 related apoptosis inducing 59 peptidic compound 59 Anticalin ® 59 phage display 59 TGF beta 59 A2A receptor 59 cyclin dependent kinase 59 RNA silencing 59 HGS ETR1 59 pro angiogenic 59 gp# [002] 59 substrate specificity 59 LEX System 59 HCV protease inhibitor 59 RAF kinase 59 tolerogenic 59 pertussis toxin 59 NKX#.# 59 Cytochrome P# 59 glycogen synthase kinase 59 nanoviricides 59 somatostatin analogue 59 kinesin spindle protein 59 cytotoxic T 59 Enkephalin 59 antisense inhibition 59 DNA demethylation 59 Notch receptors 59 rxRNA compounds 59 therapeutic monoclonal antibody 59 Protease inhibitors 59 microRNA 59 transmembrane receptor 59 pharmacodynamic biomarkers 59 adipogenic 59 tumor angiogenesis 59 pyruvate kinase 59 upregulation 59 transgenic mouse models 59 EGFR tyrosine kinase inhibitors 59 co stimulatory molecules 59 cyclin dependent kinase CDK 59 calcineurin 59 AAV2 59 PI3K pathway 59 oral kinase inhibitor 59 outer membrane proteins 59 tubulin inhibitor 59 RAS MAPK pathway 59 potent anticancer 59 novel VDA molecule 59 reverse transcriptase inhibitors 59 GM CSF 59 KIT mutations 59 HER1 59 mammalian cells 59 irreversible inhibitor 59 Mcl 1 59 diagnostic biomarker 59 immune modulator 59 soluble receptor 59 GMX# 59 microRNA miRNA 59 E1A 59 cyclic peptide 59 TLR3 59 GPx 59 aberrantly activated 59 anti mitotic 59 RNA antagonists 59 immunotoxins 59 EGFR HER2 59 sphingolipid 59 genes encoding 59 heterodimers 59 biocatalysts 59 allosteric modulators 59 targeted radiotherapeutic 59 nucleotide analogs 59 CCR2 receptor 59 apoptosis inducing 59 Smad3 59 ghrelin receptor 59 COX enzymes 59 fatty acid biosynthesis 59 Pertuzumab 59 cytostatic 59 sunitinib Sutent ® 59 polyamine 59 PI3 Kinase 59 anti proliferative 59 Spiegelmers ® 59 integrins 59 Nanobodies ® 59 EP1 receptor 59 paxillin 59 BiTE antibody 59 casein kinase 59 IFN gamma

Back to home page